AVXL - Anavex Life Sciences Forvard P/S multiplikatori
Anavex Life Sciences blarcamesine imkoniyatlaridan foydalangan holda Parkinson va Altsgeymer kasalliklariga qarshi kurashishning innovatsion usullarini ishlab chiqmoqda. Kutilayotgan P/S koeffitsiyenti tushum prognozlariga nisbatan bozor baholash dinamikasini aks ettiradi, bunda ushbu metrikaning joriy darajasini ifodalaydi. Biroq, daromadli bo'lmaganlik va FDA qarorlariga bog'liqlik sezilarli xatarlarni yuzaga keltirmoqda, aktivning kapitalizatsiyasi esa iqtisodiy sikllarni butunlay e'tiborsiz qoldiradi.
anavex.com (AVXL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Anavex Life Sciences|AVXL - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Anavex|AVXL - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Anavex|AVXL - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Anavex Life Sciences|Tezkor likvidlik koeffitsiyenti anavex.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AVXL - Kompaniyaning sof daromadi|Kutilayotgan foyda Anavex Life Sciences|AVXL - Narx-foyda multiplikatori|Forvard P/E multiplikatori anavex.com|AVXL - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Anavex Life Sciences Corp|AVXL - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Anavex Life Sciences|AVXL - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi anavex.com|AVXL - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Anavex Life Sciences
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Anavex Life Sciences Corp AVXL
Anavex Life Sciences nevrologik dori vositalarini ishlab chiqishga e'tibor qaratadi, bunda tadqiqot samaradorligi global ta'minot zanjiri logistikasining aniqligiga bog'liq. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini kutilayotgan kelajakdagi daromadlar bilan solishtirib, choraklik hisobotlarning hissiy tebranishlarini neytrallashtiradi. Bu investorga istiqbolli ishlanmalar uchun haddan tashqari ko'p to'lash xavfini baholash orqali biznesning adolatli qiymatini aniqlashga yordam beradi. Forward price-to-sales ko'rsatkichi asosidagi tahlil turli bozor ssenariylari bo'yicha aktivning xavfsizlik zaxirasini aniqlash imkonini beradi.
Anavex Life Sciences (AVXL) raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
